Evidence-Based Management of Anticoagulant Therapy
Anne Holbrook(McMaster University), Gordon Guyatt(Impact), Per Olav Vandvik(Kleijnen Systematic Reviews (United Kingdom)), Mark Crowther(Population Health Research Institute), Sam Schulman(Thrombosis and Atherosclerosis Research Institute), David L. Veenstra(University of Washington), Michael J. Kovacs(Western University), Peter J. Svensson(Skåne University Hospital), Jason Fish(University of California, Los Angeles), Daniel M. Witt(University of Utah)
Cited by 1,259
Related Papers
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|Journal of Thrombosis and Haemostasis|2009|3.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
|New England Journal of Medicine|2009|2.6k